KEGG   PATHWAY: psiu05212
Entry
psiu05212                   Pathway                                
Name
Pancreatic cancer - Phocoena sinus (vaquita)
Description
Infiltrating ductal adenocarcinoma is the most common malignancy of the pancreas. When most investigators use the term 'pancreatic cancer' they are referring to pancreatic ductal adenocarcinoma (PDA). Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways. Although EGF receptors are conventionally regarded as upstream activators of RAS proteins, they can also act as RAS signal transducers via RAS-induced autocrine activation of the EGFR family ligands. Moreover, PDA shows extensive genomic instability and aneuploidy. Telomere attrition and mutations in p53 and BRCA2 are likely to contribute to these phenotypes. Inactivation of the SMAD4 tumour suppressor gene leads to loss of the inhibitory influence of the transforming growth factor-beta signalling pathway.
Class
Human Diseases; Cancer: specific types
Pathway map
psiu05212  Pancreatic cancer
psiu05212

Organism
Phocoena sinus (vaquita) [GN:psiu]
Gene
116760326  KRAS; GTPase KRas isoform X1 [KO:K07827]
116752953  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
116752990  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
116751286  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
116750604  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
116742613  phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
116751944  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
116747322  ARHGEF6; rho guanine nucleotide exchange factor 6 isoform X1 [KO:K05729]
116761737  LOW QUALITY PROTEIN: ras-related C3 botulinum toxin substrate 1-like [KO:K04392]
116739565  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
116760236  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
116745822  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
116754222  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
116758150  RELA; transcription factor p65 isoform X1 [KO:K04735]
116743673  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
116759669  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
116748950  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
116741676  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
116746707  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
116747398  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
116758242  BAD; bcl2-associated agonist of cell death [KO:K02158]
116739841  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
116757481  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
116747370  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
116759212  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
116761625  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
116747589  MAP2K1; LOW QUALITY PROTEIN: dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
116738910  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
116740620  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
116754735  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
116741257  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
116751302  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
116755498  RALGDS; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
116759480  RALA; ras-related protein Ral-A [KO:K07834]
116756440  RALB; ras-related protein Ral-B isoform X1 [KO:K07835]
116739231  RALBP1; ralA-binding protein 1 isoform X1 [KO:K08773]
116752435  CDC42; cell division control protein 42 homolog [KO:K04393]
116746315  PLD2; phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
116753650  PLD1; phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
116764662  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
116754608  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
116759758  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
116745518  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
116751184  MTOR; serine/threonine-protein kinase mTOR isoform X1 [KO:K07203] [EC:2.7.11.1]
116745009  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
116756336  JAK1; tyrosine-protein kinase JAK1 isoform X1 [KO:K11217] [EC:2.7.10.2]
116745657  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
116757187  STAT1; signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220]
116762165  VEGFA; vascular endothelial growth factor A [KO:K05448]
116756160  CDKN2A; cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
116760381  CDK4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
116759522  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
116757387  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
116743055  RB1; retinoblastoma-associated protein [KO:K06618]
116740076  E2F1; transcription factor E2F1 [KO:K17454]
116748863  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
116762281  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
116745739  TP53; cellular tumor antigen p53 [KO:K04451]
116762584  CDKN1A; cyclin-dependent kinase inhibitor 1 isoform X1 [KO:K06625]
116756129  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
116740948  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
116752262  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
116744670  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
116762061  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
116757742  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
116750717  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
116743550  TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
116747679  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
116749145  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
116755848  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
116761798  TGFBR2; TGF-beta receptor type-2 [KO:K04388] [EC:2.7.11.30]
116738762  SMAD2; mothers against decapentaplegic homolog 2 [KO:K04500]
116749508  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
116764896  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
116743061  BRCA2; breast cancer type 2 susceptibility protein isoform X1 [KO:K08775]
116749227  RAD51; DNA repair protein RAD51 homolog 1 [KO:K04482]
116752562  DNA repair protein RAD51 homolog 1-like [KO:K04482]
Compound
C00416  Phosphatidate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
  Authors
Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu J, Wang H, Chatterjee D, Fleming JB, Li M, Abbruzzese JL, Chiao PJ
  Title
Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells.
  Journal
Clin Cancer Res 19:549-59 (2013)
DOI:10.1158/1078-0432.CCR-12-0032
Related
pathway
psiu04010  MAPK signaling pathway
psiu04012  ErbB signaling pathway
psiu04110  Cell cycle
psiu04115  p53 signaling pathway
psiu04151  PI3K-Akt signaling pathway
psiu04210  Apoptosis
psiu04350  TGF-beta signaling pathway
psiu04370  VEGF signaling pathway
psiu04630  JAK-STAT signaling pathway
KO pathway
ko05212   
LinkDB

DBGET integrated database retrieval system